You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
欧盟指明年9月底前接收2亿剂辉瑞疫苗
阿思达克 12-29 14:46
欧盟委员会发言人表示,美国辉瑞药厂(PFE.US))及德国BioNTech(BNTX.US)将於明年9月完成付运他们研发的新冠疫苗,合共2亿剂。欧盟亦正按订单附带的额外购买权,商讨购买额外1亿剂,意味欧盟仍需其他疫苗供应商供应疫苗。

欧盟目前仅批准该款疫苗使用,并已展开大规模疫苗接种,但接种行动已出现混乱情况。在德国北部一间护理院,8名工人获注射建议剂量5倍的疫苗,4人需要送院。德国南部有1,000剂疫苗没有按规定以超低温储存需被弃置。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account